Although COVID-19 is considered to be primarily a respiratory disease, SARS-CoV-2 affects
multiple organ systems including the central nervous system (CNS). Yet, there is no …

Identification of host genes essential for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection may reveal novel therapeutic targets and inform our understanding of …

Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious
complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV-2 infection…

Study objective The goal of this study is to create a predictive, interpretable model of early
hospital respiratory failure among emergency department (ED) patients admitted with …

There are currently limited Food and Drug Administration (FDA)-approved drugs and
vaccines for the treatment or prevention of Coronavirus Disease 2019 (COVID-19). Enhanced …

Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe
COVID-19. However, the immune signatures associated with immunopathology are poorly …

SARS-CoV-2, the causative agent of COVID-19, has tragically burdened individuals and
institutions around the world. There are currently no approved drugs or vaccines for the …

During clathrin‐mediated endocytosis ( CME ), a flat patch of membrane is invaginated and
pinched off to release a vesicle into the cytoplasm. In yeast CME , over 60 proteins—…

Aims Heart failure (HF) guidelines place patients into 3 discrete groups according to left
ventricular ejection fraction (LVEF): reduced (<40%), mid‐range (40–49%), and preserved LVEF …

Importance Left ventricular assist devices (LVADs) improve outcomes in patients with
advanced heart failure, but little is known about the role of neurohormonal blockade (NHB) in …